DOCSLIB.ORG

Annual Report 2005-2006 Clariant Chemicals (India) Limited Clariant Chemicals (India) Limited (Formerly Known As Colour-Chem Limited)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Annual Report 2005-2006 Clariant Chemicals (India) Limited Clariant Chemicals (India) Limited (Formerly Known As Colour-Chem Limited) Annual Report 2005-2006 Clariant Chemicals (India) Limited Clariant Chemicals (India) Limited (Formerly known as Colour-Chem Limited) Corporate Information BOARD OF DIRECTORS Mr. R. A. Shah – Chairman (w.e.f. 25th March, 2006) Mr. H. Meier – Vice-Chairman & Managing Director (w.e.f. 1st April, 2006) Mr. B. S. Mehta Diwan A. Nanda Mr. K. J. Bharucha – (Vice-Chairman & Managing Director upto 31st March, 2006) Mr. P. Lindner – (Chairman upto 24th March, 2006) Dr. A. Walde Mr. W. Mohr Mr. Sunil K. Nayak – Chief Financial Officer & Company Secretary AUDIT COMMITTEE Mr. R. A. Shah – Chairman Diwan A. Nanda Mr. K. J. Bharucha MANAGEMENT COMMITTEE Mr. H. Meier – Chairman Mr. Sunil K. Nayak Mr. A. K. Prasad Dr. G. G. Patkar Dr. S. Siddhan Mr. S. S. Patil AUDITORS A. F. Ferguson & Co., Chartered Accountants INTERNAL AUDITORS Mahajan & Aibara, Chartered Accountants SOLICITORS Crawford Bayley & Co. BANKERS The Hongkong & Shanghai Banking Corpn. Ltd. Standard Chartered Bank Citibank N.A. REGISTERED OFFICE Ravindra Annexe 194, Churchgate Reclamation Mumbai-400 020 WORKS Dhatav, Roha, Dist. Raigad-402 116 Balkum, Thane-400 608 ANNUAL GENERAL MEETING Kolshet Road, Thane-400 607 Date : 27th July, 2006 Kudikadu, P. O., Cuddalore-607 005 TIme : 03.00 p.m. Singhadivakkam Village, Kanchipuram-631 561 Day : Thursday Venue: Y. B. Chavan Auditorium REGISTRAR & SHARE TRANSFER AGENTS Gen. J. B. Marg Sharepro Services (India) Pvt. Limited Next to Sachivalaya Gymkhana Satam Estate, Chakala, Andheri (E) Mumbai - 400 021 Mumbai-400 099 1 Clariant Chemicals (India) Limited (Formerly known as Colour-Chem Limited) Notice NOTICE is hereby given that the FORTY-NINTH ANNUAL appointed as a Director of the Company whose term of GENERAL MEETING of the Members of Clariant Chemicals office shall be liable to determination by retirement of (India(India) Limited will be held at Y. B. Chavan Auditorium, Gen. directors by rotation.” Jagannath Bhosale Marg, Next to Sachivalaya Gymkhana, 6. To consider and, if thought fit, to pass, with or without Mumbai – 400 021 on Thursday July 27, 2006 at 03.00 p.m. to modification, the following resolution as an Ordinary transact the following business: resolution: Ordinary Business: “RESOLVED THAT Dr. A. Walde, who was appointed 1. To receive, consider, approve and adopt the Balance as an Additional Director of the Company by the Board Sheet as at March 31, 2006 and the Profit and Loss of Directors with effect from 01.08.05, pursuant to Account for the year ended on that date together with Article 113 of the Articles of Association of the Company the Reports of the Directors and Auditors thereon. and who holds office up to the day of this Annual General Meeting under section 260 of the Companies 2. To declare a dividend for the year 2005-2006. Act, 1956, and being eligible, offers himself for re- 3. To appoint M/s A. F. Ferguson & Co., Chartered appointment and in respect of whom the Company has Accountants, as the Auditors of the Company to hold received notice in writing under section 257 of the office from the conclusion of this Annual General Companies Act, 1956, along with the prescribed Meeting until the conclusion of the next Annual General deposit, from a shareholder signifying his intention to Meeting and to authorise the Board of Directors to fix propose Dr. Walde as a candidate for the office of their remuneration. Director, be and is hereby appointed as a Director of the Company whose term of office shall be liable to Special Business: determination by retirement of Directors by rotation.” 4. To consider and, if thought fit, to pass, with or without 7. To consider and, if thought fit, to pass, with or without modification, the following resolution as an Ordinary modification, the following resolution as an Ordinary resolution: resolution: “RESOLVED THAT Mr. B. S. Mehta, who was appointed “RESOLVED THAT Mr. K. J. Bharucha, who was as a Director of the Company by the Board of Directors appointed as an Additional Director of the Company by with effect from 25.03.06 in the casual vacancy caused the Board of Directors with effect from 01.04.06, pursuant by the resignation of Mr. H. K. Bilpodiwala and who to Article 113 of the Articles of Association of the holds office up to the day of this Annual General Company and who holds office up to the day of this Meeting under section 262 of the Companies Act, 1956, Annual General Meeting under section 260 of the and being eligible, offers himself for re-appointment Companies Act, 1956, and being eligible, offers himself and in respect of whom the Company has received for re-appointment and in respect of whom the Company notice in writing under section 257 of the Companies has received notice in writing under section 257 of the Act, 1956, along with the prescribed deposit, from a Companies Act, 1956, along with the prescribed deposit, shareholder signifying his intention to propose from a shareholder signifying his intention to propose Mr. Mehta as a candidate for the office of Director, be Mr. Bharucha as a candidate for the office of Director, and is hereby appointed as a Director of the Company be and is hereby appointed as a Director of the Company whose term of office shall be liable to determination by whose term of office shall be liable to determination by retirement of Directors by rotation.” retirement of Directors by rotation.” 5. To consider and, if thought fit, to pass, with or without 8. To consider and, if thought fit, to pass, with or without modification, the following resolution as an Ordinary modification, the following resolution as an Ordinary resolution: resolution: “RESOLVED THAT Mr. W. Mohr, who was appointed as “RESOLVED THAT Mr. H. Meier, who was appointed a Director of the Company by the Board of Directors as an Additional Director of the Company by the Board with effect from 25.03.06 in the casual vacancy caused of Directors with effect from 29.08.05, pursuant to by the resignation of Mr. P. R. Rastogi and who holds Article 113 of the Articles of Association of the office upto the day of this Annual General Meeting Company and who holds office up to the day of this under section 262 of the Companies Act, 1956, and Annual General Meeting under section 260 of the being eligible, offers himself for re-appointment and in Companies Act, 1956, and being eligible, offers respect of whom the Company has received notice in himself for re-appointment and in respect of whom writing under section 257 of the Companies Act, 1956, the Company has received notice in writing under along with the prescribed deposit, from a shareholder section 257 of the Companies Act, 1956, along with the signifying his intention to propose Mr. Mohr as a prescribed deposit, from a shareholder signifying his candidate for the office of Director, be and is hereby intention to propose Mr. Meier as a candidate for the 2 Notice office of Director, be and is hereby appointed as a remuneration payable to the Vice Chairman & Director of the Company.” Managing Director shall be governed by Section II of 9. To consider and, if thought fit, to pass, with or without Part II of Schedule XIII of the Companies Act, 1956, or modification, the following resolution as an Ordinary any statutory modification thereof. resolution: RESOLVED FURTHER THAT in accordance with Articles “RESOLVED THAT pursuant to the provisions of 127 of the Articles of Association of the Company, Sections 198, 269, 309, 310 and in terms of Schedule XIII Mr. Meier shall not be subject to retirement by rotation and other applicable provisions, if any, of the during his tenure as Vice Chairman & Managing Companies Act, 1956, approval of members be and is Director. hereby accorded to the re-appointment of Mr. K. J. RESOLVED FURTHER THAT the Board of Directors of Bharucha as Vice Chairman & Managing Director of the Company be and is hereby authorised to alter and the Company for a period of six months from 1st vary the aforesaid terms as to remuneration (including October 2005 upon the terms and conditions including perquisites) within the ceiling limits in that behalf laid remuneration, benefits and perquisites payable or down in Schedule XIII to the Companies Act, 1956 as in extended to him as set out in the agreement between force from time to time. the Company and Mr. Bharucha, copy whereof initialed RESOLVED FURTHER THAT in the event of any statutory by the Chairman for the purpose of identification has amendment, modification or relaxation by the Central been placed before this meeting, which agreement is Government to Schedule XIII to the Companies Act, hereby specifically approved. 1956, the board of Directors of the company (herein RESOLVED FURTHER THAT in the event of absence or after referred to as ‘the Board’ which term shall be inadequacy of net profit in financial year, the deemed to include any Committee which the Board remuneration payable to the Managing Director shall may constitute to exercise its powers, including be governed by Section II of Part II of Schedule XIII of powers conferred by this resolution) be and is hereby the Companies Act, 1956, or any statutory modification authorised to vary and/or increase the remuneration thereof. including salary, commission, perquisites, allowances, RESOLVED FURTHER THAT the Board of Directors of etc., within such prescribed limit(s) or ceiling and the the Company be and is hereby authorised to alter and agreement between the Company and the Vice vary the aforesaid terms as to remuneration (including Chairman & Managing Director be suitably amended to perquisites) within the ceiling limits in that behalf laid give effect to such modification, relaxation or variation down in Schedule XIII to the Companies Act, 1956 as in without any further reference to the members of the force from time to time.
Load more

Recommended publications
  • The Future of Digital Transformation and Innovation Unconference
    The Future of Digital Transformation and Innovation unConference 6 October 2016 USERNAME: PASSWORD: Practical Solutions Your Business for the 4th Industrial Revolution Brussels, Belgium, by The Conference Board Celebrating its 100 Year Anniversary! CONFIRMED SPEAKERS Brian Anderson Associate Program Director The Demand Institute ( jointly operated by The Conference Board and Nielsen ) Andrea Bonime-Blanc CEO GEC Risk Advisory Lindsey Canning Partner, Intellectual Property White & Case LLP London Bonnie Cheuk Director, Global Head of Digital, Knowledge & Social Collaboration Euroclear Kieran Conlon VP Sales & Services International Globoforce Martin Curley Former VP & Director Intel Labs Europe Intel Corporation David Dab Chief Innovation Officer ING Belgium Wim De Waele CEO Eggsplore John Higgins Director General Digital Europe Richard Hughes Director of Social Strategy BroadVision Joshua Jost Chief Storyteller Anderson Walsh Spencer Mark Leiter Chairman Leiter & Company Bertrand Liard Partner, Intellectual Property White & Case LLP Paris Jacquelyn MacLennan Partner, Competition White & Case LLP Brussels and London Ann Mettler Head of European Political Strategy Centre European Commission Dragan Pendic Head of Digital & Data Trust RelianceACSN Wil Schoenmakers Management Group PA Consulting Philippe Trichet Digital Expert Director Boston Consulting Group Nicolas van Zeebroeck Innovation and Digital Business Solvay Brussels School Philip Weiss Author of “Hyperthinking”, Founder ZN Sponsors WHY? WHO? Digital is set to revolutionize the The unConference is designed for 400+ C-suite and senior level executives, world. Is your company set for this? leading different functions in large organizations and different industries. Businesses have always changed—in reaction to changes in the marketplace WHAT? or in capabilities. But digital The event will be an integrated blend of transformation presents a new 1.
    [Show full text]
  • Julius Baer Multicooperation Annual Report 2005 As at June 30, 2005 (Audited)
    Julius Baer Multicooperation Annual Report 2005 as at June 30, 2005 (audited) Subscriptions are only valid if made on the basis of the current Prospectus, the latest Annual Report and the latest Semi-Annual Report if published thereafter. The Articles of Association, the valid Prospectus and the Annual and Semi-Annual Reports may be obtained free of charge at the representative in Switzerland and the respective paying agent. Only the German version of the present Annual Report has been reviewed by the independent auditor. Consequently, the independent auditor's report only refers to the German version of the Report; other versions result from a conscientious translation made under the responsibility of the Board. In case of differences between the German version and the translation, the German version shall be the authentic text. AN INVESTMENT FUND DOMICILED IN LUXEMBOURG Representative in Switzerland: Julius Baer Investment Funds Services Ltd., Zurich Paying agent in Switzerland: Bank Julius Bär & Co. AG, Bahnhofstrasse 36, Postfach, CH - 8010 Zurich Paying agent in Germany: Bank Julius Bär (Deutschland) AG, Messe Turm, Friedrich-Ebert-Anlage 49, Postfach 15 01 52, D - 60061 Frankfurt on the Main Paying agent in Austria: Erste Bank der oesterreichischen Sparkassen AG, Graben 21, A - 1010 Vienna Contents Page Organisation and Management 4 Independent Auditor's Report 5 Notes to the Financial Statements 6 Julius Baer Multicooperation (Umbrella Fund) MCOO Julius Baer Multicooperation - Emerging Markets Value Stock Fund HESF Julius Baer Multicooperation
    [Show full text]
  • Applications at Novartis Pharma AG Fieldbus
    FuRIOS 2 Feldbus und Remote I/OSystemvergleich Fieldbus and Remote I/O System Comparison ”The Fieldbus is ready for practical use“ FuRIOS 2 Fieldbus and Remote I/O System Comparison Preface Prof. Dr.-Ing. Birgit Vogel-Heuser, Institute of Automation Technology/Process Informatics at Bergische University Wuppertal Preface to second, updated edition Prof. Dr.-Ing. habil. Lothar Litz Institute of Automation Technology Technical University Kaiserslautern FuRIOS: Fieldbus and Remote I/O – a system comparison Published in atp – Automatisierungstechnische Praxis 44 (2002), Edition 12/2002, pages 61 - 70 Dr.-Ing. Thomas Tauchnitz, Aventis Pharma Deutschland GmbH Dipl.-Ing. Wilfried Schmieder, Aventis Pharma Deutschland GmbH Dipl.-Ing. Sven Seintsch, Infraserv GmbH & Co Höchst KG Fieldbus and Remote I/O: System Comparison „FuRIOS“ Presentation at the NAMUR general assembly, 08.11.2002 Dr.-Ing. Thomas Tauchnitz, Aventis Pharma Deutschland GmbH Fieldbus Experience Reports Presentation at the NAMUR general assembly, 04.11.2004 Martin Schwibach, BASF Thomas Meier-Künzig, DSM Sven Seintsch, infraserv höchst technik Dr. Joachim Zobel, Novartis Push-button telephones were the first step on the way to the mobile phone Interview mit Dr.-Ing. Thomas Tauchnitz, Aventis Pharma Deutschland GmbH Manfred Dietz, Infraserv GmbH & Co Höchst KG Savings are not the goal of fieldbus Interview with Frans van Laak, Speaker of NAMUR working group 2.6 „Fieldbusses“ Harry van Rijt, DSM TechnoPartners From theorie to practical use Aventis applies FuRIOS study in real pharmaceutical
    [Show full text]
  • Julius Baer Multistock Société D'investissement À Capital Variable
    Julius Baer Multistock Société d'Investissement à Capital Variable Annual Report as at 30 June 2011 (audited) Subscriptions are carried out solely on the basis of the current prospectus or the simplified prospectus, or the “key investor information”, as soon as it is available, in conjunction with the latest annual report and the latest semi-annual report if published thereafter. The articles of association, the valid prospectus and the simplified prospectus, the annual and semi-annual reports (or the “key investor information”, as soon as it is available), as well as the information based on the SFA guidelines on transparency with regard to management fees, may be obtained free of charge from the representative in Switzerland and/or from the respective paying agent. In case of differences between the German version and the translation, the German version shall be the authentic text. AN INVESTMENT FUND DOMICILED IN LUXEMBOURG Representative in Switzerland: Swiss & Global Asset Management AG, Hardstraße 201, CH - 8005 Zurich (new address from 19 September 2011) Paying agent in Switzerland: Bank Julius Bär & Co. AG, Bahnhofstraße 36, Postfach, CH - 8010 Zurich Paying and information agent in Germany (until 31 December 2010): Bank Julius Bär Europe AG, An der Welle 1, Postfach 15 02 52, D - 60062 Frankfurt am Main Paying agent in Germany (since 1 January 2011): Deka Bank Deutsche Girozentrale, Hahnstraße 55, D - 60528 Frankfurt am Main Information agent in Germany (since 1 January 2011): Swiss & Global Asset Management Kapital AG, Taunusanlage 15, D - 60325 Frankfurt am Main Paying agent in Austria: Erste Bank der oesterreichischen Sparkassen AG, Graben 21, A - 1010 Vienna Representative and paying agent in Liechtenstein: LGT Bank in Liechtenstein AG, Herrengasse 12, FL - 9490 Vaduz Trade and Companies Register number: R.C.S.
    [Show full text]
  • 2018 Compensation Report to a Principles Applicable to Performance-Related Pay and to the Consultative Vote at the 2019 Annual General Meeting
    84 Givaudan – 2018 Integrated Annual Report 85 Compensation report In this section 86 Compensation governance 87 Compensation principles 88 Compensation of Givaudan executives 93 Compensation of the Executive Committee 94 Compensation of the Board of Directors 96 Share ownership guidelines 96 Ownership of Givaudan securities 97 Report of the statutory auditor Givaudan – 2018 Integrated Annual Report 86 Compensation report Compensation report Attract, motivate and retain performance targets and related payouts under the annual incentives and share-based long-term incentives, while the Givaudan aims to attract, applicable performance criteria are set by the Board. motivate and retain a diverse The Compensation Committee is also responsible for pool of highly talented people to reviewing and approving individual compensation and benefits of each Executive Committee member as well as sustain its leadership position recommending compensation for the Board. within the flavour and fragrance The Compensation Committee consists of three independent industry. The Company’s members of the Board and is currently chaired by Prof. Dr-Ing. Werner Bauer. The Chief Executive Officer is regularly invited to compensation policies are an Compensation Committee meetings. The Head of Global Human Resources acts as secretary of the Compensation Committee. essential component of this The Chairman of the Compensation Committee may invite other strategy, and as such a key driver executives as appropriate. However, executives do not participate in discussions regarding their own compensation. of organisational performance. The Compensation Committee meets three to five times a year Our compensation programmes are aligned to our strategy and and informs the Board of its deliberations, recommendations and reflect the performance of the business and of individuals.
    [Show full text]
  • Julius Baer Multistock Société D'investissement À Capital Variable
    Julius Baer Multistock Société d'Investissement à Capital Variable Annual Report as at 30 June 2015 (audited) Subscriptions are carried out solely on the basis of the current prospectus or the key investor information, in conjunction with the latest annual report and the latest semi- annual report if published thereafter. The articles of association, the valid prospectus and the key investor information, the annual and semi-annual reports, as well as the information based on the SFAMA guidelines on transparency with regard to management fees, may be obtained free of charge from the representative in Switzerland and/or from the respective paying agent. In case of differences between the German version and the translation, the German version shall be the authentic text. AN INVESTMENT FUND DOMICILED IN LUXEMBOURG Representative in Switzerland: GAM Investment Management (Switzerland) AG, Hardstraße 201, P.O. Box, CH - 8037 Zurich Paying agent in Switzerland: Bank Julius Bär & Co. AG, Bahnhofstraße 36, P.O. Box, CH - 8010 Zurich Paying agent in Germany: DekaBank Deutsche Girozentrale, Hahnstraße 55, D - 60528 Frankfurt / Main Information agent in Germany: GAM (Deutschland) AG, Taunusanlage 15, D - 60325 Frankfurt am Main Paying agent in Austria: Erste Bank der oesterreichischen Sparkassen AG, Graben 21, A - 1010 Vienna Trade and Companies Register number: R.C.S. Luxembourg B-32188 Contents Page Organisation and Management 4 Information on risk management (unaudited) 6 Audit Report 7 Report of the Board of Directors 9 Notes to the Annual Report
    [Show full text]
  • Vontobel Documentation Derivatives
    Public Offer 1/8 7.00% p.a. Callable Multi Defender Vonti on Clariant, Lonza, Sonova Final Terms SSPA Designation Barrier Reverse Convertible (1230) Contact +41 58 283 78 88 www.derinet.com In Switzerland, these financial instruments are considered structured products. They are not collective investment schemes within the meaning of the Swiss Federal Act on Collective Investment Schemes (CISA), and are therefore not subject to the regulations of the CISA or the supervision of the Swiss Financial Market Supervisory Authority FINMA. The investors bear the Issuer's credit risk. Summary This summary constitutes an introduction to the prospectus. Investment decisions must not be based on the introduction but on the information contained in the entire prospectus. The issuer accepts no liability for the summary unless the summary itself is misleading, incorrect or contradictory when read together with the other parts of the prospectus. Important information on the Securities Issuer Bank Vontobel AG, Zurich (Moody's Long Term Deposit Rating: Aa3) Lead Manager Bank Vontobel AG, Zurich ISIN / Swiss Security Number / Symbol CH0595158475 / 59515847 / RMCJYV SSPA Designation Barrier Reverse Convertible (1230), see also www.sspa.ch Initial Fixing 30 April 2021 Payment Date 07 May 2021 Final Fixing 31 October 2022 Repayment Date 07 November 2022 Redemption / Delivery see "Redemption / Delivery" below Underlyings Clariant AG, Registered Share Lonza Group AG, Registered Share Sonova Holding AG, Registered Share Settlement Cash payment and/or physical
    [Show full text]
  • SIX Swiss Exchange Message No. 20/2021
    SIX Swiss Exchange message no. 20/2021 Subject Index adjustments on the occasion of the ordinary index review Category Index Adjustments Authorized by Marcus Müntener, Area Head Customer & Data Operations Christian Bahr, Head Index Services Pages 3 Date 07.07.2021 Information Content of this message: - Index adjustments on the occasion of the ordinary index review The Swiss Index Committee of SIX Financial Information has decided to make changes to the index baskets on the basis of a recommendation from the Index Commission and in compliance with the SMI®, SLI®, SPI® and SXI® index rules. The indices will be adjusted on 17 September 2021 after closing. The adjustment takes effect on 20 September 2021. Changes to the SMI® and SPI®20 index baskets Admission to the SMI® and SPI®20 LOGITECH N CH0025751329 Exclusion from the SMI® and SPI®20 SWATCH GROUP I CH0012255151 Changes to the SMIM® index basket Admission to the SMIM® SWATCH GROUP I CH0012255151 ZUR ROSE GROUP N CH0042615283 Exclusion from the SMIM® LOGITECH N CH0025751329 OC OERLIKON N CH0000816824 Changes to the SLI® index basket Admission to the SLI® VIFOR N CH0364749348 SIX Swiss Exchange Ltd T + 41 58 399 5454 Pfingstweidstrasse 110 F + 41 58 499 5455 P.O. Box www.six-group.com CH-8021 Zurich SIX Swiss Exchange message no. 20/2021 07.07.2021 Exclusion from the SLI® CLARIANT N CH0012142631 SLI® 9% cappings Based on the SLI® index rules, section 7.14.4 , and according to the capping selection list 9% 1, the weight of the following securities will be limited to 9%: NESTLE N CH0038863350
    [Show full text]
  • Clariant Signs New Syndicated Revolving Credit Facility Agreement
    Media Release Clariant signs new Syndicated Revolving Credit Facility Agreement Muttenz, December 19, 2016 – Clariant, a world leader in specialty chemicals, today announced the signing of a new CHF 500 million five-year multi-currency Revolving Credit Facility (RCF) with two one-year extension options. The unsecured RCF has been structured as a club deal and contains an accordion option to increase the facility up to CHF 600 million. The syndicate consists of a key relationship bank group comprising Citigroup Global Markets Limited (Coordinator), The Bank of Tokyo-Mitsubishi UFJ, Ltd., BNP Paribas (SUISSE) SA, Commerzbank Aktiengesellschaft, Filiale Luxemburg, Credit Suisse (Switzerland) Ltd., Deutsche Bank Luxembourg S.A., Landesbank Hessen-Thüringen Girozentrale, LBBW Landesbank Baden-Württemberg, SEB AG and UBS Switzerland AG as mandated lead arrangers and bookrunners. The RCF is structured as a “back-stop” facility for rating purposes to maintain Clariant’s liquidity headroom. The RCF works as a safeguard and allows more efficient cash usage implying a reduction of financing costs of around CHF 3 million per annum. CORPORATE MEDIA RELATIONS INVESTOR RELATIONS JOCHEN DUBIEL ANJA POMREHN Phone +41 61 469 63 63 Phone +41 61 469 67 45 [email protected] [email protected] CLAUDIA KAMENSKY STEVEN MASSHEDER Phone +41 61 469 63 63 Phone +41 61 469 68 58 [email protected] [email protected] Follow us on Twitter, Facebook, Google Plus, LinkedIn. www.clariant.com Clariant is a globally leading specialty chemicals company, based in Muttenz near Basel/Switzerland. On 31 December 2015 the company employed a total workforce of 17 213.
    [Show full text]
  • Annual Report Annual Report
    Annual Report 2012 Financial SUMMARY KEY FIGURES in CHF m 2012 2011 Sales 1 6 038 5 571 EBITDA before exceptionals 1 802 835 EBITDA margin before exceptionals (%) 1 13.3 15.0 EBIT before exceptionals 1 531 624 Net income 238 251 Basic earnings per share 1 0.70 0.77 Operating cash flow 2 468 314 Investment in property, plant and equipment 311 370 Research & Development costs 1 175 140 Total assets 9 525 9 105 3 Equity 3 040 3 026 Equity ratio (%) 31.9 33.3 Net financial debt 1 789 1 740 Gearing ratio 4 (%) 59 58 Employees 21 202 22 149 1 Continuing operations (see note 1.04 in the Financial Report) 2 Starting from 2012, interest paid and received are reported as part of financing cash flow. 2011 number has been restated accordingly. 3 Restated (see note 1.03 in the Financial Report) 4 Net financial debt to equity SALES by BUSINEss UNIT in CHF m SALES by Region in CHF m Total 2012: 6 038 Total 2012: 6 038 Industrial 1 474& 24 % Consumer EuropeSpecialties 2 228 37 % Masterbatches 1 121 19 % Asia / Pacific 1 414 23 % Pigments 899 15 % Middle 537 9 % East & Africa Oil 715 12 % & MiningLatin 903 15 % ServicesAmerica Additives 1 411 7 % Functional 667 11 % Materials North 956 16 % America Catalysis 751 12 % & Energy 1 Additives, the remaining part of the former Performance Chemicals, also comprises the activities of Emulsions in Morocco and the New Business Development with combined sales of around CHF 20 million. Why is CLARIANT SUccEssfUL? Where we want to go – Our Vision BRAND VALUE PERFORMANCE: We aim to be the global leading company for specialty chemicals Our customers and their performance deserve our appreciation.
    [Show full text]
  • Remuneration Report
    Letter to Shareholders Overview Business Highlights Sustainability Our People Financial Reports Governance Remuneration Report Remuneration Report Dear Shareholders, Committee members, the determination of the remuneration of the members of Executive Committee, as well as the On behalf of the Nomination and Compensation Committee, preparation of the Remuneration Report and of the say-on- I am pleased to share with you the Remuneration Report for pay vote at the Annual General Meeting. the fiscal year 2018/19. This Remuneration Report has been You will find further information on the activities of the prepared in accordance with the “Ordinance against NCC and on Barry Callebaut’s remuneration programs on Excessive Compensation in listed Companies” (OaEC), the following pages. Art. 663c paragraph 3 of the Swiss Code of Obligations and the Corporate Governance Directive issued by SIX At the 2019 General Meeting, we will request your approval Exchange Regulation. of the total remuneration amount to be awarded to the Board In the fiscal year 2018/19, the Group achieved strong of Directors for the period until the following General results with profitable growth and good cash generation Meeting, the maximum aggregate amount of fixed driven by a consistent execution of its ‘smart growth’ remuneration to be awarded to the Executive Committee in strategy. fiscal year 2020/21, and the maximum aggregate amount of This reports explains how the performance in the variable remuneration awarded to the Executive Committee reporting year impacted the compensation paid to the in fiscal year 2018/19. Additionally, you will have the Executive Committee under the incentive plans. opportunity to express your opinion on this Remuneration During the reporting year, the Nomination and Report in a consultative vote.
    [Show full text]
  • Innovations-Award 2020/21 C - Chemistry; Metallurgy / D - Textiles; Paper
    Innovations-Award 2020/21 C - Chemistry; Metallurgy / D - Textiles; Paper D - Textiles; Paper C01 Inorganic Chemistry Score Casale SA 10,00 Imerys Graphite & Carbon Switzerland SA 3,85 OMYA Development AG 2,91 Clariant 2,47 ETH Zürich 2,03 General Electric Technology GmbH 1,86 EMPA Eidgenössische Materialprüfungs- und Forschungsanstalt 1,64 SICPA 1,46 EPFL 1,03 Sika Tech AG 1,01 NOVA Chemicals Corporation 0,96 Xylem Europe GmbH 0,91 Swatch Group Res & Dev Ltd 0,80 Holcim 0,74 Roche 0,72 Lonza AG 0,62 Paul Scherrer Institut 0,58 C02 Treatment of Water, Waste Water, Sewage, or Sludge Score Solenis 10,00 Clariant 4,89 Xylem Europe GmbH 4,07 Nestlé S.A. (incl. Nestec S.A.) 3,92 General Electric Technology GmbH 3,69 Aquis Wasser-Luft-Systeme GmbH 2,88 Baxter Healthcare SA 2,58 Geberit 2,23 Sulzer Chemtech AG 1,80 HYTECON AG 1,68 EPFL 1,40 Franke Technology & Trademark 1,27 Jura Elektroapparate AG 1,22 AVALON Industries AG 1,20 Vestergaard SA 1,20 Seas Société De L´Eau Aérienne Suisse SA 1,14 Sonatec Suisse Fribourg-Vaud Sárl 1,12 Erwin Suter AG - Maschinenfabrik Retus 1,11 LUQEL 1,08 Tetra Laval International SA 0,95 Eawag 0,94 Wanhua Chemical Group Co. 0,89 Every Award Winner sorted by CPC-Classes 1/10 Innovations-Award 2020/21 C - Chemistry; Metallurgy / D - Textiles; Paper C03 Glass, Mineral or Slag Wool Score Emhart Glass SA 10,00 Sika Tech AG 5,97 Flumroc AG 4,24 Cartier 3,95 EPFL 3,02 Comadur SA 2,91 IS Engineering AG 2,88 Nivarox-Far SA 2,79 Sager AG 2,62 Glas Trösch 2,42 C04 Cements; Concrete; artificial Stone; Ceramics, Refractories
    [Show full text]